Sirnaomics Ltd

NEW
FRA:V5Z (China)  
€ 0.49 (0%) Jul 1
At Loss
Market Cap:
€ 56.22M ($ 64.26M)
Enterprise V:
€ 39.85M ($ 45.54M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Description
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China. All of the company's revenue is derived from the mainland of the People's Republic of China (the PRC). The pipeline includes: STP705, STP707, STP355, STP369, STP705, STP122G, STP125G, and STP144G.
Name Current Vs Industry Vs History
Cash-To-Debt
1.45
Equity-to-Asset
-0.48
Debt-to-Equity
-0.94
Debt-to-EBITDA
-0.7
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
53
3-Year EPS without NRI Growth Rate
50.3
3-Year FCF Growth Rate
58.9
Name Current Vs Industry Vs History
5-Day RSI
42.24
9-Day RSI
43.16
14-Day RSI
42.4
3-1 Month Momentum %
-18.66
6-1 Month Momentum %
-33.13
12-1 Month Momentum %
16.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.4
Quick Ratio
0.4
Cash Ratio
0.35

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-6.5
Shareholder Yield %
-14.72

Profitability Rank

Name Current Vs Industry Vs History
ROA %
-61.52
ROIC %
-37.62
3-Year ROIIC %
-504.04
ROC (Joel Greenblatt) %
-231.7

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-3.31
EV-to-EBITDA
-3.43
EV-to-FCF
-4.92
Earnings Yield (Greenblatt) %
-30.21
FCF Yield %
-14.44

Financials

FRA:V5Z's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Sirnaomics Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.129
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 116.55
14-Day RSI 42.4
14-Day ATR (€) 0.022618
20-Day SMA (€) 0.49925
12-1 Month Momentum % 16.95
52-Week Range (€) 0.432 - 2.34
Shares Outstanding (Mil) 108.9

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sirnaomics Ltd Filings

Filing Date Document Date Form
No Filing Data

Sirnaomics Ltd Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

Sirnaomics Ltd Frequently Asked Questions

What is Sirnaomics Ltd(FRA:V5Z)'s stock price today?
The current price of FRA:V5Z is €0.49. The 52 week high of FRA:V5Z is €2.34 and 52 week low is €0.43.
When is next earnings date of Sirnaomics Ltd(FRA:V5Z)?
The next earnings date of Sirnaomics Ltd(FRA:V5Z) is .
Does Sirnaomics Ltd(FRA:V5Z) pay dividends? If so, how much?
Sirnaomics Ltd(FRA:V5Z) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Sirnaomics Ltd

No articles.